EMEA-002600-PIP03-21
Key facts
| Invented name |
Aspaveli
|
| Active substance |
Pegcetacoplan
|
| Therapeutic area |
Uro-nephrology
|
| Decision number |
P/0284/2022
|
| PIP number |
EMEA-002600-PIP03-21
|
| Pharmaceutical form(s) |
Solution for infusion
|
| Condition(s) / indication(s) |
Treatment of glomerulonephritis and nephrotic syndrome
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Apellis Ireland Limited
E-mail: info@apellis.com |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|